JP2023080234A5 - - Google Patents

Download PDF

Info

Publication number
JP2023080234A5
JP2023080234A5 JP2023065084A JP2023065084A JP2023080234A5 JP 2023080234 A5 JP2023080234 A5 JP 2023080234A5 JP 2023065084 A JP2023065084 A JP 2023065084A JP 2023065084 A JP2023065084 A JP 2023065084A JP 2023080234 A5 JP2023080234 A5 JP 2023080234A5
Authority
JP
Japan
Prior art keywords
hpmcas
liquid solution
ethenocycloprop
isoindol
octahydro
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023065084A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023080234A (ja
Filing date
Publication date
Priority claimed from JP2020195121A external-priority patent/JP7681393B2/ja
Application filed filed Critical
Publication of JP2023080234A publication Critical patent/JP2023080234A/ja
Publication of JP2023080234A5 publication Critical patent/JP2023080234A5/ja
Pending legal-status Critical Current

Links

JP2023065084A 2013-07-19 2023-04-12 アモルファステコビリマット調製 Pending JP2023080234A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201361856240P 2013-07-19 2013-07-19
US61/856,240 2013-07-19
JP2020195121A JP7681393B2 (ja) 2013-07-19 2020-11-25 アモルファステコビリマット調製

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2020195121A Division JP7681393B2 (ja) 2013-07-19 2020-11-25 アモルファステコビリマット調製

Publications (2)

Publication Number Publication Date
JP2023080234A JP2023080234A (ja) 2023-06-08
JP2023080234A5 true JP2023080234A5 (enExample) 2025-07-02

Family

ID=52346653

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2016526997A Active JP6843616B2 (ja) 2013-07-19 2014-07-11 アモルファステコビリマット調製
JP2020195121A Active JP7681393B2 (ja) 2013-07-19 2020-11-25 アモルファステコビリマット調製
JP2023065084A Pending JP2023080234A (ja) 2013-07-19 2023-04-12 アモルファステコビリマット調製

Family Applications Before (2)

Application Number Title Priority Date Filing Date
JP2016526997A Active JP6843616B2 (ja) 2013-07-19 2014-07-11 アモルファステコビリマット調製
JP2020195121A Active JP7681393B2 (ja) 2013-07-19 2020-11-25 アモルファステコビリマット調製

Country Status (8)

Country Link
US (3) US9670158B2 (enExample)
EP (2) EP3763702B1 (enExample)
JP (3) JP6843616B2 (enExample)
CN (2) CN105307636A (enExample)
AU (1) AU2014290333B2 (enExample)
CA (3) CA2917199C (enExample)
IL (1) IL242331B (enExample)
WO (1) WO2015009566A1 (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105307636A (zh) * 2013-07-19 2016-02-03 西佳技术公司 非晶形特考韦瑞制备
CN107126419B (zh) * 2016-02-26 2020-06-19 石药集团中诺药业(石家庄)有限公司 一种奥贝胆酸片剂及其制备方法
CN112955130A (zh) * 2018-10-30 2021-06-11 佩洛通治疗公司 包含取代茚满的固体分散体和药物组合物及其制备和使用方法
CN115141136B (zh) * 2021-03-31 2023-06-20 中国人民解放军军事科学院军事医学研究院 特考韦瑞药的共晶及其制备方法

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PE20011184A1 (es) 2000-03-16 2001-11-15 Pfizer Prod Inc Composiciones farmaceuticas de inhibidores de la glucogeno-fosforilasa
US6596771B2 (en) 2001-01-12 2003-07-22 Schering Corporation Drugs for treating viral infections
US6433016B1 (en) 2001-01-12 2002-08-13 Vassil Stefanov Georgiev Drugs for treating viral infections
US7687641B2 (en) 2003-06-20 2010-03-30 Siga Technologies, Inc. Chemicals, compositions, and methods for treatment and prevention of orthopoxvirus infections and associated diseases
PL1638938T3 (pl) 2003-06-20 2017-10-31 Siga Tech Inc Związki, kompozycje i sposoby do leczenia i zapobiegania infekcjom ortopokswirusami i powiązanym chorobom
WO2006110655A2 (en) * 2005-04-08 2006-10-19 Chimerix, Inc. Compounds, compositions and methods for the treatment of poxvirus infections
JP2010526848A (ja) * 2007-05-11 2010-08-05 エフ.ホフマン−ラ ロシュ アーゲー 難溶性薬物用の医薬組成物
PE20170944A1 (es) * 2010-03-23 2017-07-13 Siga Tech Inc Formas polimorficas de st-246 y metodos de preparacion
RU2566716C2 (ru) * 2010-06-09 2015-10-27 Эббви Бахамаз Лтд. Твердые дисперсии, содержащие ингибиторы киназ
GB201103837D0 (en) * 2011-03-07 2011-04-20 Oxagen Ltd Amorphous (5-Fluoro-2-Methyl-3-Quinolin-2-Ylmethyl-Indol-1-Yl)-acetic acid
WO2012122279A1 (en) * 2011-03-08 2012-09-13 Zalicus Pharmaceuticals Ltd. Solid dispersion formulations and methods of use thereof
KR102000312B1 (ko) * 2011-10-14 2019-07-15 어레이 바이오파마 인크. Erb2 (her2) 저해제의 고체 분산물
JP2013103899A (ja) * 2011-11-11 2013-05-30 Fuji Chem Ind Co Ltd 難溶性薬物の新規な固体分散体
CN102406617B (zh) * 2011-11-30 2013-08-28 中国人民解放军军事医学科学院生物工程研究所 一种替韦立马干混悬剂及其制备方法
CN105307636A (zh) 2013-07-19 2016-02-03 西佳技术公司 非晶形特考韦瑞制备

Similar Documents

Publication Publication Date Title
JP2719344B2 (ja) 徐放性製剤
RU2372893C2 (ru) Содержащий фармацевтический агент состав с покрытием
JP2009538315A (ja) 塩酸デュロキセチン遅延放出型製剤
RU2018146513A (ru) Твердые формы венетоклакса и способы получения венетоклакса
CN1419446A (zh) 缓释制剂及其制法
RU2008109651A (ru) Ядра микропеллет панкреатина, пригодные для нанесения энтеросолюбильного покрытия
CN1489455A (zh) 延释药物制剂
CN102970982B (zh) 肠溶片剂
CN110123782A (zh) 含有药物的中空颗粒
JP2002526437A (ja) アジテーション非依存性薬学的マルチプル−ユニット持効性製剤およびその製法
RU2602955C2 (ru) Фармацевтические композиции антагонистов метаботропного глутаматного рецептора 5 (mglu5)
JP2002529399A (ja) 粒状化結晶性イブプロフェンで被覆した粒子
CA2555295C (en) Extended release coated mini-tablets of venlafaxine hydrochloride
JP2007507491A (ja) 徐放性製剤
CN1110304C (zh) 用于口服的含有活性成份硝苯吡啶的缓释药物组合物
JP2016527229A5 (enExample)
CA2586124A1 (en) Formulations of [1,4]diazepino[6,7,1-ij]quinoline derivatives
US20040228916A1 (en) Pharmaceutical solid preparation containing a poorly soluble drug and production process thereof
WO2005007138A1 (en) Pharmaceutical formulations
WO2012123922A1 (en) Controlled release pharmaceutical compositions of selective serotonin reuptake inhibitor
CN1839846A (zh) 左氧氟沙星缓释微丸、其制备方法及其用途
CN1549705A (zh) 新的缓释口服剂型
RU2727721C2 (ru) Фармацевтическая композиция с замедленным высвобождением, содержащая ривастигмин
KR20250053128A (ko) 센타나파딘을 포함하는 제약 조성물
KR100510270B1 (ko) 펠렛타이저를 이용한 서방성 제제의 제조방법